Role of B-type natriuretic peptide as a marker of mortality in acute kidney injury patients treated with continuous renal replacement therapy

References

• Ahlstrom A, Tallgren M, Peltonens S, Rasanen P, Pettila V. Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med. 2005;31(9):1222–1228
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care. 2005;9(6):R700–R709
   Web of Science ®Google Scholar
• Korkeila M, Ruokonen E, Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med. 2000;26(12):1824–1831
   PubMed Web of Science ®Google Scholar
• Uchinos S. The epidemiology of acute renal failure in the world. Curr Opin Crit Care. 2006;12(6):538–543
   PubMed Web of Science ®Google Scholar
• Bellomo R, Mehta R. Acute renal replacement in the intensive care unit: now and tomorrow. New Horiz. 1995;3(4):760–767
   PubMedGoogle Scholar
• Canaud B, Mion C. Extracorporeal treatment of acute renal failure: methods, indications, quantified and personalized therapeutic approach. Adv Nephrol Necker Hosp. 1995;24:271–313
   PubMedGoogle Scholar
• Barton IK, Hilton PJ, Taub NA, et al. Acute renal failure treated by hemofiltration: factors affecting outcome. Q J Med. 1993;86(2):81–90
   PubMedGoogle Scholar
• Sasaki S, Gando S, Kobayashi S, et al. Predictors of mortality in patients treated with continuous hemofiltration for acute renal failure in an intensive care setting. ASAIO. 2001;47(1):86–91
   PubMed Web of Science ®Google Scholar
• de Denus S, Pharand C, Williamson DR. Brain natriuretic peptide in the management of heart failure: the versatile neurohormone. Chest. 2004;125(2):652–668
   PubMed Web of Science ®Google Scholar
• Azzazy HM, Christenson RH. B-type natriuretic peptide: physiologic role and assay characteristics. Heart Fail Rev. 2003;8(4):315–320
   PubMed Web of Science ®Google Scholar
• Januzzi JrJL, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95(8):948–954
   PubMed Web of Science ®Google Scholar
• Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161–167
   PubMed Web of Science ®Google Scholar
• Rudiger A, Gasser S, Fischler MN, Hornemann T, von Eckardstein A, Maggiorini M. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006;34(8):2140–2144
   PubMed Web of Science ®Google Scholar
• Rana R, Vlahakis NE, Daniels CE Rana R, Vlahakis NE, Daniels C. B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med. 2006;34(7):1941–1946
   PubMed Web of Science ®Google Scholar
• Lega JC, Lacasse Y, Lakhal L, Provencher S. Natriuretic peptides and troponins in pulmonary embolisms: a meta-analysis. Thorax. 2009;64(10):869–875
   PubMed Web of Science ®Google Scholar
• James ML, Blessing R, Phillips-Bute BG, Bennett E, Laskowitz DT. S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral hemorrhage. Biomarkers. 2009;14(6):388–394
   PubMed Web of Science ®Google Scholar
• Rivers EP, McCord J, Otero R, Jacobsen G, Loomba M. Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med. 2007;22(6):363–373
   PubMedGoogle Scholar
• Hoffmann U, Brueckmann M, Bertsch T, et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab. 2005;51(7–8):373–379
   PubMed Web of Science ®Google Scholar
• Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international cocsensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):204–212
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ system failure. Ann Surg. 1985;202(6):685–693
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis definitions Conference. Crit Care Med. 2003;31(4):1250–1256
   PubMed Web of Science ®Google Scholar
• Prowle JR, Bellomo R. Continuous renal replacement therapy: recent advancement and future research. Nat Rev Nephrol. 2010;6(9):521–529
   PubMed Web of Science ®Google Scholar
• Schwilk B, Wiedeck H, Stein B, reinelt H, Treber H, Bothner U. Epidemiology of acute renal failure and outcome of hemodiafiltration in intensive care. Intensive Care Med. 1997;23(12):1204–1211
   PubMed Web of Science ®Google Scholar
• Baudouin SV, Wiggins J, Keogh BF, Morgan CJ, Evans TW. Continuous veno-venous hemofiltration following cardio-pulmonary bypass. Indications and outcome in 35 patients. Intensive Care Med. 1993;19(5):290–293
   PubMed Web of Science ®Google Scholar
• Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of arterial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology. 1993;132(5):1961–1970
   PubMed Web of Science ®Google Scholar
• Tokola H, Hautala N, Marttila M, et al. Mechanical load-induced alterations in B-type natriuretic peptide gene expression. Can J Physiol Pharmacol. 2001;79(8):646–653
   PubMed Web of Science ®Google Scholar
• Mollamach F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 2001;59(4):1559–1566
   PubMed Web of Science ®Google Scholar
• Sakr Y, Vincent JL, Reinhart K, et al. Sepsis Occurrence in Acute Ill Patients Investigations. High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest. 2005;128(5):3098–3108
   PubMed Web of Science ®Google Scholar
• Vincent JL, Sakr Y, Sprung CL, et al. Sepsis Occurrence in Acute Ill patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–353
   PubMed Web of Science ®Google Scholar
• Daniels LB, Allison MA, Clopton P, et al. Use of natriuretic peptides in pre-participation screening of college athletes. Int J Cardiol. 2008;124(3):411–414
   PubMed Web of Science ®Google Scholar
• de Cal M, Haapio M, Cruz DN, et al. B-type natriuretic peptide in the critically ill with acute kidney injury. Int J Nephrol. 2011;951629:1–6
   Google Scholar
• Fulop T, Pathak MB, Schmidt DW, et al. Volume-Related weight gain and subsequent mortality in acute renal failure patients treated with continuous renal replacement therapy. ASAIO J. 2010;56(4):333–337
   PubMed Web of Science ®Google Scholar
• McLean AS, Huang SJ, Hyams S, et al. Prognostic value of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med. 2007;35(4):1019–1026
   PubMed Web of Science ®Google Scholar
• Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol. 2004;36(4):505–513
   PubMed Web of Science ®Google Scholar
• DeFilippi CR, Fink JC, Nass CM, Cher H, Christenson R. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis. 2005;46:35–44
   PubMed Web of Science ®Google Scholar
• Khan IA, Fink J, Nass C, Chen H, Christenson R, de Filippi CR. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol. 2006;97(10):1530–1534
   PubMed Web of Science ®Google Scholar
• Mark PB, Stewart GA, Gansevoort RT, et al. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Tranplant. 2006;21(2):402–410
   PubMed Web of Science ®Google Scholar
• Takami Y, Horio T, Iwashima Y, et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis. 2004;44(3):420–428
   PubMed Web of Science ®Google Scholar
• Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37(2):386–391
   PubMed Web of Science ®Google Scholar